FDA Head Seeks IG Probe Of Biogen Alzheimer's Drug Talks
The acting head of the Food and Drug Administration said Friday that she had asked for an investigation into conversations between members of her agency and Biogen representatives prior to the...To view the full article, register now.
Already a subscriber? Click here to view full article